Skip to search.
 FTSE 100 Up 0.39%

Hyperion Therapeutics, Inc. (HPTX)

-NasdaqGS
29.73 Down 0.05(0.17%) 4 Mar 21:00
Add to Portfolio
Prev Close:29.78
Open:29.58
Bid:29.71 x 700
Ask:29.75 x 600
1y Target Est:36.67
Beta:0.66
Earnings Date:4 May - 8 May (Est.)
Day's Range:28.59 - 29.95
52wk Range:20.23 - 30.59
Volume:195,686
Avg Vol (3m):169,780
Market Cap:616.21m
P/E (ttm):N/A
EPS (ttm):-0.31
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
HPTXDown 0.17%616.21m
ALXNUp 0.01%36.90b
CPIXUp 3.59%115.08m
SLXPUp 0.40%10.03b

Key Statistics

Forward P/E (1 yr):64.63
P/S (ttm):5.43
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :0.64
Quarterly EPS Est (Mar-15) :0.20
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Hyperion Therapeutics, Inc., a commercial biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat disorders in the areas of orphan diseases and hepatology. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback